DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 2,650.00
-100.00 (-3.64%)
Oct 8, 2026, 3:30 PM KST
DK Life Science Market Cap
DK Life Science has a market cap or net worth of 84.76 billion as of October 8, 2026. It is the 28,699th most valuable company in the world and the 1,441st biggest in South Korea. Its market cap has decreased by 35.44% in one year.
Market Cap
84.76B
Enterprise Value
114.23B
Revenue
117.75B
Global Rank
Country Rank
#1,441 South Korea
PE Ratio
17.02
ChartMarket Cap Chart
Since February 17, 2025, DK Life Science's market cap has decreased from 200.38B to 84.76B, a decrease of -57.70%. That is a compound annual growth rate of -40.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 84.76B | -27.60% |
| Dec 30, 2025 | 117.06B | -41.58% |
| Feb 17, 2025 | 200.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 59.05T |
| Celltrion | 41.92T |
| ALTEOGEN | 16.71T |
| Samsung Epis Holdings | 8.59T |
| NEUROPHET | 90.39B |
| Kukje Pharma | 90.21B |
| Osang Healthcare Co.,Ltd | 89.71B |
| iNtRON Biotechnology | 88.35B |